Murine coronavirus induces type I interferon in oligodendrocytes through recognition by RIG-I and MDA5.

Jianfeng Li, Yin Liu, Xuming Zhang
Author Information
  1. Jianfeng Li: Department of Microbiology and Immunology, University of Arkansas for Medical Sciences, 4301 W. Markham Street, Little Rock, AR 72205, USA.

Abstract

The murine coronavirus mouse hepatitis virus (MHV) induced the expression of type I interferon (alpha/beta interferon [IFN-alpha/beta]) in mouse oligodendrocytic N20.1 cells. This induction is completely dependent on virus replication, since infection with UV light-inactivated virus could no longer induce IFN-alpha/beta. We show that MHV infection activated both transcription factors, the IFN regulatory factor 3 (IRF-3) and nuclear factor kappaB (NF-kappaB), as evidenced by phosphorylation and nuclear translocation of IRF-3 and an increased promoter binding activity for IRF-3 and NF-kappaB. Furthermore, the cytoplasmic pattern recognition receptor retinoic acid-inducible gene I (RIG-I) was induced by MHV infection. Knockdown of RIG-I by small interfering RNAs blocked the activation of IRF-3 and subsequent IFN-alpha/beta production induced by MHV infection. Knockdown of another cytoplasmic receptor, the melanoma-differentiation-associated gene 5 (MDA5), by small interfering RNAs also blocked IFN-beta induction. These results demonstrate that MHV is recognized by both RIG-I and MDA5 and induces IFN-alpha/beta through the activation of the IRF-3 signaling pathway. However, knockdown of RIG-I only partially blocked NF-kappaB activity induced by MHV infection and inhibition of NF-kappaB activity by a decoy peptide inhibitor had little effect on IFN-alpha/beta production. These data suggest that activation of the NF-kappaB pathway might not play a critical role in IFN-alpha/beta induction by MHV infection in oligodendrocytes.

References

  1. Nat Rev Immunol. 2008 Jul;8(7):559-68 [PMID: 18575461]
  2. J Virol. 2004 Aug;78(15):7867-73 [PMID: 15254159]
  3. J Virol. 2002 Apr;76(8):3697-708 [PMID: 11907209]
  4. J Virol. 2007 Jul;81(13):7189-99 [PMID: 17459917]
  5. Cell. 2002 Dec 27;111(7):927-30 [PMID: 12507420]
  6. J Virol. 2003 Nov;77(22):11952-63 [PMID: 14581532]
  7. Methods. 2001 Dec;25(4):402-8 [PMID: 11846609]
  8. J Neurochem. 1993 Feb;60(2):577-87 [PMID: 7678286]
  9. Nature. 2006 May 4;441(7089):101-5 [PMID: 16625202]
  10. J Virol. 2009 Dec;83(23):12204-14 [PMID: 19776127]
  11. J Virol. 2005 Jan;79(1):47-56 [PMID: 15596800]
  12. Adv Virus Res. 1997;48:1-100 [PMID: 9233431]
  13. Cardiovasc Toxicol. 2006;6(2):111-30 [PMID: 17303919]
  14. Nat Immunol. 2004 May;5(5):503-7 [PMID: 15064760]
  15. Virology. 1997 Jun 23;233(1):1-8 [PMID: 9201212]
  16. Annu Rev Biochem. 1998;67:227-64 [PMID: 9759489]
  17. Virology. 2007 Apr 25;361(1):18-26 [PMID: 17316733]
  18. Nature. 2006 Jul 6;442(7098):39-44 [PMID: 16823444]
  19. J Mol Biol. 2003 Aug 29;331(5):991-1004 [PMID: 12927536]
  20. J Virol. 2007 Mar;81(6):2554-63 [PMID: 17182678]
  21. Immunity. 2005 Jul;23(1):19-28 [PMID: 16039576]
  22. Mol Cell. 2005 Sep 16;19(6):727-40 [PMID: 16153868]
  23. Eur J Biochem. 1998 Jun 1;254(2):248-55 [PMID: 9660177]
  24. Ann N Y Acad Sci. 2008 Nov;1143:1-20 [PMID: 19076341]
  25. J Virol. 2007 Jan;81(2):568-74 [PMID: 17079305]
  26. PLoS Biol. 2008 Sep 16;6(9):e226 [PMID: 18798692]
  27. Immunol Rev. 2009 Jan;227(1):54-65 [PMID: 19120475]
  28. Cell. 2005 Sep 9;122(5):669-82 [PMID: 16125763]
  29. J Virol. 2008 Jan;82(1):300-10 [PMID: 17928334]
  30. J Immunol. 2005 Sep 1;175(5):2851-8 [PMID: 16116171]
  31. Nature. 2001 Oct 18;413(6857):732-8 [PMID: 11607032]
  32. Cold Spring Harb Symp Quant Biol. 1998;63:609-20 [PMID: 10384326]
  33. J Virol. 2009 Oct;83(20):10653-63 [PMID: 19570858]
  34. Nat Rev Immunol. 2007 Oct;7(10):753-66 [PMID: 17893693]
  35. J Immunol. 2002 Dec 15;169(12):6668-72 [PMID: 12471095]
  36. Cell. 2006 Feb 24;124(4):783-801 [PMID: 16497588]
  37. Mol Cell. 2008 Feb 1;29(2):169-79 [PMID: 18243112]
  38. Mol Cell. 2008 Feb 29;29(4):428-40 [PMID: 18242112]
  39. Nat Immunol. 2005 Oct;6(10):981-8 [PMID: 16127453]
  40. Nat Rev Microbiol. 2006 Feb;4(2):121-32 [PMID: 16415928]
  41. Nat Rev Immunol. 2005 May;5(5):375-86 [PMID: 15864272]
  42. Immunity. 2007 Sep;27(3):370-83 [PMID: 17892846]
  43. Eur J Biochem. 2004 Sep;271(18):3693-703 [PMID: 15355347]
  44. Nat Immunol. 2003 Feb;4(2):161-7 [PMID: 12539043]
  45. J Virol. 2008 Oct;82(20):9829-38 [PMID: 18667505]
  46. Nature. 2007 Oct 18;449(7164):819-26 [PMID: 17943118]
  47. Virology. 2004 Jan 5;318(1):381-92 [PMID: 14972563]
  48. Nat Immunol. 2006 Feb;7(2):131-7 [PMID: 16424890]
  49. Proc Natl Acad Sci U S A. 1998 Dec 22;95(26):15623-8 [PMID: 9861020]
  50. Nature. 2005 Oct 20;437(7062):1167-72 [PMID: 16177806]
  51. Nat Immunol. 2003 May;4(5):491-6 [PMID: 12692549]
  52. Eur J Biochem. 1984 Aug 15;143(1):165-74 [PMID: 6088228]
  53. J Virol. 1999 Jan;73(1):290-6 [PMID: 9847332]

Grants

  1. R01 NS047499/NINDS NIH HHS
  2. U01 AI061204/NIAID NIH HHS
  3. P30 NS047546/NINDS NIH HHS
  4. AI061204/NIAID NIH HHS
  5. NS047499/NINDS NIH HHS

MeSH Term

Animals
Cell Line
DEAD Box Protein 58
DEAD-box RNA Helicases
Gene Knockdown Techniques
Interferon Regulatory Factor-3
Interferon Type I
Interferon-Induced Helicase, IFIH1
Mice
Murine hepatitis virus
NF-kappa B
Oligodendroglia
Phosphorylation
Protein Binding
Protein Processing, Post-Translational
Protein Transport

Chemicals

Interferon Regulatory Factor-3
Interferon Type I
NF-kappa B
Ddx58 protein, mouse
Ifih1 protein, mouse
DEAD Box Protein 58
DEAD-box RNA Helicases
Interferon-Induced Helicase, IFIH1

Word Cloud

Created with Highcharts 10.0.0MHVinfectionIFN-alpha/betaIRF-3NF-kappaBRIG-IinducedvirusinterferoninductionactivityblockedactivationMDA5coronavirusmousetypefactornuclearcytoplasmicrecognitionreceptorgeneKnockdownsmallinterferingRNAsproductioninducespathwayoligodendrocytesmurinehepatitisexpressionalpha/beta[IFN-alpha/beta]oligodendrocyticN201cellscompletelydependentreplicationsinceUVlight-inactivatedlongerinduceshowactivatedtranscriptionfactorsIFNregulatory3kappaBevidencedphosphorylationtranslocationincreasedpromoterbindingFurthermorepatternretinoicacid-induciblesubsequentanothermelanoma-differentiation-associated5alsoIFN-betaresultsdemonstraterecognizedsignalingHoweverknockdownpartiallyinhibitiondecoypeptideinhibitorlittleeffectdatasuggestmightplaycriticalroleMurine

Similar Articles

Cited By